File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: LONG-TERM PREDICTIVE VALUE OF BLEEDING ON PROBING IN PERI‑IMPLANTITIS DIAGNOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

TitleLONG-TERM PREDICTIVE VALUE OF BLEEDING ON PROBING IN PERI‑IMPLANTITIS DIAGNOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Authors
KeywordsDental implant
Evidence-based dentistry
Mucositis
Periodontal diseases
Prevalence
Systematic review
Issue Date2024
Citation
Journal of Evidence-Based Dental Practice, 2024, v. 24, n. 4, article no. 102034 How to Cite?
AbstractObjective: This systematic review and meta-analysis aimed to evaluate the diagnostic value of bleeding on probing (BOP) for peri‑implantitis detection on implant- and patient-levels, as reported in prospective and retrospective studies with at least 5 years of follow-up. Materials and Methods: A systematic search of 3 electronic databases was conducted and supplemented with a hand-search to identify clinical studies that reported the prevalence of peri‑implantitis and BOP after at least 5 years of functional loading. Random-effects meta-analyses were conducted to combine the proportions of peri‑implantitis among BOP positive implants and patients across studies. Heterogeneity was explored with subgroup analyses. Results: 5826 patients and 17,198 implants were included in this review. Definitions of peri‑implantitis varied between studies. Thirty studies were included for assessment. Implant-level meta-analysis was conducted in 24 studies and patient-level meta-analysis in 19 studies. Overall proportion of peri‑implantitis in BOP-positive implants was 26.5% (95% CI, 21.2 to 32.1) and 35.1% (95% CI, 27.4 to 43.1) in BOP-positive patients. Substantial heterogeneity was present, and prediction intervals were 5.2%-56% and 6.4%-71.5% at the implant- and patient-level, respectively. Conclusion: Within the limitations, prevalence of peri‑implantitis was found to be around 1 third in both BOP-positive implants and patients. Prevalence varied between studies. Although a guiding clinical factor in the diagnosis of peri‑implantitis, clinicians should be aware of the significant false-positive rates of BOP.
Persistent Identifierhttp://hdl.handle.net/10722/354402
ISSN
2023 Impact Factor: 4.1
2023 SCImago Journal Rankings: 1.023
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorYu, Xinbo-
dc.contributor.authorLin, Xinyan-
dc.contributor.authorWang, Feng-
dc.contributor.authorWu, Yiqun-
dc.date.accessioned2025-02-07T08:48:23Z-
dc.date.available2025-02-07T08:48:23Z-
dc.date.issued2024-
dc.identifier.citationJournal of Evidence-Based Dental Practice, 2024, v. 24, n. 4, article no. 102034-
dc.identifier.issn1532-3382-
dc.identifier.urihttp://hdl.handle.net/10722/354402-
dc.description.abstractObjective: This systematic review and meta-analysis aimed to evaluate the diagnostic value of bleeding on probing (BOP) for peri‑implantitis detection on implant- and patient-levels, as reported in prospective and retrospective studies with at least 5 years of follow-up. Materials and Methods: A systematic search of 3 electronic databases was conducted and supplemented with a hand-search to identify clinical studies that reported the prevalence of peri‑implantitis and BOP after at least 5 years of functional loading. Random-effects meta-analyses were conducted to combine the proportions of peri‑implantitis among BOP positive implants and patients across studies. Heterogeneity was explored with subgroup analyses. Results: 5826 patients and 17,198 implants were included in this review. Definitions of peri‑implantitis varied between studies. Thirty studies were included for assessment. Implant-level meta-analysis was conducted in 24 studies and patient-level meta-analysis in 19 studies. Overall proportion of peri‑implantitis in BOP-positive implants was 26.5% (95% CI, 21.2 to 32.1) and 35.1% (95% CI, 27.4 to 43.1) in BOP-positive patients. Substantial heterogeneity was present, and prediction intervals were 5.2%-56% and 6.4%-71.5% at the implant- and patient-level, respectively. Conclusion: Within the limitations, prevalence of peri‑implantitis was found to be around 1 third in both BOP-positive implants and patients. Prevalence varied between studies. Although a guiding clinical factor in the diagnosis of peri‑implantitis, clinicians should be aware of the significant false-positive rates of BOP.-
dc.languageeng-
dc.relation.ispartofJournal of Evidence-Based Dental Practice-
dc.subjectDental implant-
dc.subjectEvidence-based dentistry-
dc.subjectMucositis-
dc.subjectPeriodontal diseases-
dc.subjectPrevalence-
dc.subjectSystematic review-
dc.titleLONG-TERM PREDICTIVE VALUE OF BLEEDING ON PROBING IN PERI‑IMPLANTITIS DIAGNOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.jebdp.2024.102034-
dc.identifier.pmid39631968-
dc.identifier.scopuseid_2-s2.0-85207705080-
dc.identifier.volume24-
dc.identifier.issue4-
dc.identifier.spagearticle no. 102034-
dc.identifier.epagearticle no. 102034-
dc.identifier.eissn1532-3390-
dc.identifier.isiWOS:001346446200001-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats